or Try an Advanced Search...

    Technical Analysis for RKV - Rakovina Therapeutics Inc

    Grade Last Price % Change Price Change
    C 0.090 0.00% 0.000
    RKV closed unchanged on Thursday, April 25, 2024, on 39 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical RKV trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Fell Below 20 DMA Bearish 5.88%
    Wide Bands Range Expansion 5.88%
    MACD Bearish Signal Line Cross Bearish 0.00%
    Shooting Star Candlestick Bearish 0.00%
    Lizard Bearish Bearish Day Trade Setup 0.00%
    Doji - Bearish? Reversal 0.00%
    Doji - Bullish? Reversal 0.00%
    Older End-of-Day Signals for RKV ...

       Recent Intraday Alerts

    Alert Time
    Fell Below 10 DMA about 13 hours ago
    Rose Above 10 DMA 1 day ago
    Up 5% 1 day ago
    Up 3% 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    RKV Chart by TradingView
    Basic chart:

    Profile

    Rakovina Therapeutics, Inc., formerly Vincero Capital Corp., is a Canada-based company, which is engaged in developing cancer treatments based on DNA-damage response technologies. The Company’s lead product candidate is kt-2000 Next Generation PARP-inhibitors. Its pipeline includes kt-3000 Dual Action DDR-inhibitors and kt-4000 DNA Damaging DDR-inhibitors. Its kt-2000 series is a patented class of highly potent, oral inhibitors of poly (ADP-ribose) polymerase (PARP). Its kt-3000 drug candidates selectively inhibit secondary DDR pathways associated with treatment resistance and PARP. kt-4000 drug candidates release a potent DNA-damaging agent, while also inhibiting DDR to selectively kill cancer cells.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Catalysts

    Is RKV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.25
    52 Week Low 0.005
    Average Volume 90,214
    200-Day Moving Average 0.108
    50-Day Moving Average 0.082
    20-Day Moving Average 0.091
    10-Day Moving Average 0.091
    Average True Range 0.008
    RSI (14) 55.16
    ADX 24.06
    +DI 29.015
    -DI 20.941
    Chandelier Exit (Long, 3 ATRs) 0.111
    Chandelier Exit (Short, 3 ATRs) 0.094
    Upper Bollinger Bands 0.101
    Lower Bollinger Band 0.080
    Percent B (%b) 0.46
    BandWidth 23.348
    MACD Line 0.002
    MACD Signal Line 0.003
    MACD Histogram -0.0005
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.090
    Resistance 3 (R3) 0.090 0.090 0.090
    Resistance 2 (R2) 0.090 0.090 0.090 0.090
    Resistance 1 (R1) 0.090 0.090 0.090 0.090 0.090
    Pivot Point 0.090 0.090 0.090 0.090 0.090
    Support 1 (S1) 0.090 0.090 0.090 0.090 0.090
    Support 2 (S2) 0.090 0.090 0.090 0.090
    Support 3 (S3) 0.090 0.090 0.090
    Support 4 (S4) 0.090